Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697382 · ClinicalTrials.gov registry record · NA
Effect of Daily Steps on Fat Metabolism
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03697382: Completed NA study, sponsored by University of Texas at Austin.
NCT03697382 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03697382, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Reduced ambulatory activity has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of varying levels of daily ambulation on response to a HFTT after an acute aerobic exercise bout.
Primary Outcome
Areas under the curve for triglyceride concentration will be calculated for hourly samples from a 6-hour lipid tolerance test.
Interventions
- BEHAVIORAL Very Low Steps
- BEHAVIORAL Low Steps
- BEHAVIORAL Moderate Steps
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-09-29 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
What the finished NCT03697382 record still lists
NCT03697382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Very Low Steps is the first listed.
NCT03697382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03697382 about?
NCT03697382 is a clinical study titled "Effect of Daily Steps on Fat Metabolism". Reduced ambulatory activity has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of varying levels of daily ambulation on response to a HFTT after an acute aerobic exercise bout.
What is the current status of trial NCT03697382?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-09-29. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03697382?
The interventions under investigation include: Very Low Steps (BEHAVIORAL), Low Steps (BEHAVIORAL), Moderate Steps (BEHAVIORAL).
Who is sponsoring clinical trial NCT03697382?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03697382's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI